APA (7th ed.) Citation

Lehnert, T., Röver, C., Köpke, S., Rio, J., Chard, D., Fittipaldo, A. V., . . . Rahn, A. C. (2022, July). Immunotherapy for people with clinically isolated syndrome or relapsing-remitting multiple sclerosis: Treatment response by demographic, clinical, and biomarker subgroups (PROMISE)—a systematic review protocol. Systematic Reviews.

Chicago Style (17th ed.) Citation

Lehnert, Thomas, Christian Röver, Sascha Köpke, Jordi Rio, Declan Chard, Andrea V. Fittipaldo, Tim Friede, Christoph Heesen, and Anne C. Rahn. "Immunotherapy for People with Clinically Isolated Syndrome or Relapsing-remitting Multiple Sclerosis: Treatment Response by Demographic, Clinical, and Biomarker Subgroups (PROMISE)—a Systematic Review Protocol." Systematic Reviews Jul. 2022.

MLA (9th ed.) Citation

Lehnert, Thomas, et al. "Immunotherapy for People with Clinically Isolated Syndrome or Relapsing-remitting Multiple Sclerosis: Treatment Response by Demographic, Clinical, and Biomarker Subgroups (PROMISE)—a Systematic Review Protocol." Systematic Reviews, Jul. 2022.